These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 29063293)

  • 1. Two mTOR inhibitors, rapamycin and Torin 1, differentially regulate iron-induced generation of mitochondrial ROS.
    Huang H; Chen J; Lu H; Zhou M; Chai Z; Hu Y
    Biometals; 2017 Dec; 30(6):975-980. PubMed ID: 29063293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparing mTOR inhibitor Rapamycin with Torin-2 within the RIST molecular-targeted regimen in neuroblastoma cells.
    Waetzig R; Matthes M; Leister J; Penkivech G; Heise T; Corbacioglu S; Sommer G
    Int J Med Sci; 2021; 18(1):137-149. PubMed ID: 33390782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mammalian target of Rapamycin inhibition and mycobacterial survival are uncoupled in murine macrophages.
    Zullo AJ; Jurcic Smith KL; Lee S
    BMC Biochem; 2014 Feb; 15():4. PubMed ID: 24528777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of mTOR reduces lipotoxic cell death in primary macrophages through an autophagy-independent mechanism.
    He L; Weber KJ; Diwan A; Schilling JD
    J Leukoc Biol; 2016 Nov; 100(5):1113-1124. PubMed ID: 27312848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gerosuppression by pan-mTOR inhibitors.
    Leontieva OV; Blagosklonny MV
    Aging (Albany NY); 2016 Dec; 8(12):3535-3551. PubMed ID: 28077803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of miR-19b enhanced the cytotoxic effects of mTOR inhibitors in human neuroblastoma cells.
    Chen Y; Tsai YH; Tseng BJ; Pan HY; Tseng SH
    J Pediatr Surg; 2016 Nov; 51(11):1818-1825. PubMed ID: 27492819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of mammalian target of rapamycin induces renal mitochondrial uncoupling in rats.
    Sivertsson E; Friederich-Persson M
    Adv Exp Med Biol; 2013; 789():309-314. PubMed ID: 23852509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitors of mammalian target of rapamycin downregulate MYCN protein expression and inhibit neuroblastoma growth in vitro and in vivo.
    Johnsen JI; Segerström L; Orrego A; Elfman L; Henriksson M; Kågedal B; Eksborg S; Sveinbjörnsson B; Kogner P
    Oncogene; 2008 May; 27(20):2910-22. PubMed ID: 18026138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Iron-induced generation of mitochondrial ROS depends on AMPK activity.
    Huang H; Chen J; Lu H; Zhou M; Chai Z; Hu Y
    Biometals; 2017 Aug; 30(4):623-628. PubMed ID: 28608291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapamycin-resistant and torin-sensitive mTOR signaling promotes the survival and proliferation of leukemic cells.
    Park S; Sim H; Lee K
    BMB Rep; 2016 Jan; 49(1):63-8. PubMed ID: 26497580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective targeting of human colon cancer stem-like cells by the mTOR inhibitor Torin-1.
    Francipane MG; Lagasse E
    Oncotarget; 2013 Nov; 4(11):1948-62. PubMed ID: 24185040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mammalian target of rapamycin inhibitors, temsirolimus and torin 1, attenuate stemness-associated properties and expression of mesenchymal markers promoted by phorbol-myristate-acetate and oncostatin-M in glioblastoma cells.
    Chandrika G; Natesh K; Ranade D; Chugh A; Shastry P
    Tumour Biol; 2017 Mar; 39(3):1010428317695921. PubMed ID: 28351321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The dual PI3K/mTOR inhibitor NVP-BEZ235 and chloroquine synergize to trigger apoptosis via mitochondrial-lysosomal cross-talk.
    Seitz C; Hugle M; Cristofanon S; Tchoghandjian A; Fulda S
    Int J Cancer; 2013 Jun; 132(11):2682-93. PubMed ID: 23151917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapamycin vs TORin-1 or Gleevec vs Nilotinib: Simple chemical evolution that converts PAK1-blockers to TOR-blockers or vice versa?
    Maruta H; He H
    Drug Discov Ther; 2024 Jun; 18(2):134-139. PubMed ID: 38569833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic regulation, mitochondria and the life-prolonging effect of rapamycin: a mini-review.
    Pan Y; Nishida Y; Wang M; Verdin E
    Gerontology; 2012; 58(6):524-30. PubMed ID: 22947849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Torin2 Potentiates Anticancer Effects on Adult T-Cell Leukemia/Lymphoma by Inhibiting Mammalian Target of Rapamycin.
    Watanabe T; Sato A; Kobayashi-Watanabe N; Sueoka-Aragane N; Kimura S; Sueoka E
    Anticancer Res; 2016 Jan; 36(1):95-102. PubMed ID: 26722032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hormetic effect of low doses of rapamycin triggers anti-aging cascades in WRL-68 cells by modulating an mTOR-mitochondria cross-talk.
    Mahalakshmi R; Priyanga J; Bhakta-Guha D; Guha G
    Mol Biol Rep; 2022 Jan; 49(1):463-476. PubMed ID: 34739690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tris (1, 3-dichloro-2-propyl) phosphate induces apoptosis and autophagy in SH-SY5Y cells: Involvement of ROS-mediated AMPK/mTOR/ULK1 pathways.
    Li R; Zhou P; Guo Y; Lee JS; Zhou B
    Food Chem Toxicol; 2017 Feb; 100():183-196. PubMed ID: 28025121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alleviation of neuronal energy deficiency by mTOR inhibition as a treatment for mitochondria-related neurodegeneration.
    Zheng X; Boyer L; Jin M; Kim Y; Fan W; Bardy C; Berggren T; Evans RM; Gage FH; Hunter T
    Elife; 2016 Mar; 5():. PubMed ID: 27008180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autophagy activation and protection from mitochondrial dysfunction in human chondrocytes.
    López de Figueroa P; Lotz MK; Blanco FJ; Caramés B
    Arthritis Rheumatol; 2015 Apr; 67(4):966-76. PubMed ID: 25605458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.